SCHEMBL2716479

SCHEMBL2716479

CC(=O)N1CCN(c2ccc(Nc3cc(N(c4ccccc4F)C4CC4)c(C(N)=O)cn3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2713978 0.89 SYK (0.54) SYK
SCHEMBL2712474 0.85 SYK (0.54) SYK
SCHEMBL2696712 0.84 SYK (0.58) SYK
SCHEMBL2694989 0.82 SYK (0.60) SYK
SCHEMBL2696639 0.81 SYK (0.59) SYK
SCHEMBL2716322 0.81 SYK (0.47) SYK
SCHEMBL2712299 0.80 SYK (0.55) SYK
SCHEMBL2696460 0.78 STAT6 (0.57) SYK
SCHEMBL2714357 0.78 SYK (0.54) SYK
SCHEMBL2713612 0.78 MAPK10 (0.55) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635557-A2 NICOTINAMIDES AS JAK KINASE MODULATORS Portola Pharmaceuticals, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061428-A2 NICOTINAMIDES AS JAK KINASE MODULATORS PORTOLA PHARMACEUTICALS, INC. (US) 2012-05-10 — — WO disclosed
Send feedback